-

AHF Advocates to Keep Hammering Gilead CEO over Drug Profiteering

Protest Friday, June 16th will target drug company CEO at company’s Foster City HQ

SAN FRANCISCO--(BUSINESS WIRE)--On Friday, June 16th, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF) will host a protest targeting HIV and Hepatitis C drug giant Gilead Sciences over the Bay Area company’s drug pricing and policies. The protest will take place in front of Gilead’s headquarters in Foster City, CA. The action is part of a yearlong aggressive advocacy campaign by AHF hammering Gilead and Daniel O’Day, its multimillionaire CEO, over his and the company’s drug profiteering.

WHAT:

 

Protest at Gilead Sciences HQ

 

 

 

WHEN:

 

Friday, June 16 - 12:00 p.m.

 

 

 

WHERE:

 

Gilead Sciences, Inc. Headquarters

 

 

333 Lakeside Dr., Foster City, CA 94404

 

 

 

WHO:

 

20 health advocates & mobilizers

AHF Onsite Foster City Media Contact: Jesse Brooks, +1.510.575.8245 cell jesse.brooks@ahf.org

According to CEO World Magazine, Daniel O’Day, Chairman and CEO of Gilead Sciences, was the 4th highest paid CEO in the healthcare industry in 2022 with total compensation of $21,621,253.

Advocates are protesting Gilead’s tone-deaf greed, particularly illegal restrictions the company placed early last year on access to 340B drug pricing for its branded hepatitis C treatments for certain pharmacies. Gilead now is one of more than 15 major drug companies that illegally have placed such restrictions on drugs.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth, follow us @aidshealthcare or subscribe to our AHF podcast “AHFter Hours.”

Contacts

Ged Kenslea, AHF Senior Communications Director
323.791.5526
ged.kenslea@ahf.org

AIDS Healthcare Foundation


Release Summary
Advocates to Keep Hammering Gilead CEO over Drug Profiteering
Release Versions

Contacts

Ged Kenslea, AHF Senior Communications Director
323.791.5526
ged.kenslea@ahf.org

More News From AIDS Healthcare Foundation

AHF Expands to Kyiv With Its Second HIV Clinic in Ukraine

KYIV, Ukraine--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) Ukraine has opened the first Test & Treat Clinic for HIV in Kyiv, marking another milestone in the organization's continued expansion of free HIV services amid an ongoing war. “The opening of the Test & Treat Clinic in Kyiv marks another important step toward ensuring that HIV services are fast, accessible, and free from stigma,” said Dr. Yaroslava Lopatina, Country Program Director for AHF Ukraine. “We’re bringing testing...

AHF: Florida Budget Becomes Law, Securing Reversal of HIV Drug Cuts

TALLAHASSEE, Fla.--(BUSINESS WIRE)--AHF: Florida Budget Becomes Law, Securing Reversal of HIV Drug Cuts...

After UN HIV Meeting, AHF Calls for Resources to Match Promises

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) welcomed the engagement of Member States at the 2026 United Nations High-Level Meeting on HIV/AIDS, while emphasizing that millions of people living with HIV still do not have access to lifesaving treatment, and an estimated 1.2 million people acquire HIV each year. As governments reaffirm their commitment to ending AIDS as a public health threat, AHF urged that political promises be matched by the resources needed to turn commitmen...
Back to Newsroom